A method to predict the equilibrium solubility of drugs in solid polymers near room temperature using thermal analysis

Journal of Pharmaceutical Sciences

Volumn 101, Issue 12, 2012, Pages 4549-4558

  Bellantone, Robert A ^a   Patel, Piyush ^a   Sandhu, Harpreet ^b   Choi, Duk Soon ^b   Singhal, Dharmendra ^b   Chokshi, H ^b   Malick, A Waseem ^b   Shah, Navnit ^b  

^a LONG ISLAND UNIVERSITY   (United States)

^b HOFFMANN LA ROCHE INC   (United States)

Author keywords

Amorphous; Polymers; Solid solution; Solubility; Thermal analysis; Thermodynamics

Indexed keywords

EID: 84868201540     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.23319     Document Type: Article

References (32)

1. Chiou WL, Riegelman S. 1971. Pharmaceutical applications of solid dispersion systems. J Pharm Sci 60:1281-1302.
2. Simonelli AP, Mehta SC, Higuchi WI. 1969. Dissolution rates of high energy polyvinyl pyrrolidone(PVP)-sulfathiazole coprecipitates. J Pharm Sci 58:538-549.
3. Leuner C, Dressman J. 2002. Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Biopharm 50:47-60.
4. Serajuddin ATM. 1999. Solid dispersion of poorly water-soluble drugs: Early promises, subsequent problems, and recent breakthroughs. J Pharm Sci 88:1058-1066.
5. Hildebrand J, Scott R. 1950. Solubility of non-electrolytes. 3rd ed. New York City, New York: Rheinhold.
6. Gong Y, Grant DJW, Brittain HG. 2007. Principles of solubility (Chapter 1). In Solvent systems and their selection in pharmaceutics and biopharmaceutics; Augustijns P, Brewster ME, Eds. New York City, New York: Springer-AAPS Press.
7. Yalkowsky SH. 1999. Solubility and solubilization in aqueous media. New York City, New York: Oxford University Press, Chapter 3.
8. van Krevelen DW, TeNijenhuis K. 2009. Properties of polymers. 4th ed. Amsterdam, The Netherlands: Elsevier Scientific, Chapter 7.
9. Heimenz PC, Lodge TP. 2007. Polymer chemistry. 2nd ed. Boca Raton, Florida: CRC Press, Chapter 7.
10. Flory PJ. 1953. Principles of polymer chemistry. Ithaca, New York: Cornell University Press, Chapter 12.
11. Marsac PJ, Li T, Taylor LS. 2009. Estimation of drug-polymer miscibility and solubility in amorphous solid dispersions using experimentally determined interaction parameters. Pharm Res 26:139-151.
12. Marsac PJ, Shamblin SL, Taylor LS. 2006. Theoretical and practical approaches for prediction of drug-polymer miscibility and solubility. Pharm Res 23:2417-2426.
13. Paudel A, Humbeeck JV, den Mooter GV. 2010. Theoretical and experimental investigation on the solid solubility and miscibility of naproxen in poly(vinylpyrrolidone). Mol Pharm 7:1133-1148.
14. Velaz I, Sanches M, Martin C, Martinez-Oharriz MC, Nornoza A. 1997. Interaction of naproxen with vinyl pyrrolidone and β-cyclodextrin: A fluorometric study. Int J Pharm 150:211-217.
15. Pitt CG, Bao YT, Andrady AL, Samuel PNK. 1988. The correlation of polymer-water and octanol-water partition coefficients: Estimation of drug solubilities in polymers. Int J Pharm 45:1-11.
16. Gupta J, Nunes C, Vyas S, Jonnalagadda S. 2011. Prediction of solubility parameters and miscibility of pharmaceutical compounds by molecular dynamics simulations. J Phys Chem B 115:2014-2023.
17. Greenhalgh D, Williams AC, Timmins P, York P. 1999. Solubility parameters as predictors of miscibility in solid dispersions. J Pharm Sci 88:1182-1190.
18. Lacoulonche F, Chauvet A, Masse J, Egea MA, Garcia ML. 1998. An investigation of FB interactions with poly(ethylene glycol) 6000, poly(ethylene glycol) 4000, and poly-2-caprolactone by thermoanalytical and spectroscopic methods and modeling. J Pharm Sci 87:543-551.
19. Vippagunta, SR, Wang, Z, Hornung, S, Krill, SL. 2007. Factors affecting the formation of eutectic solid dispersions and their dissolution behavior. J Pharm Sci 96:294-304.
20. Vasanthavada M, Tong W, Joshi Y, Kislalioglu MS. 2004. Phase behavior of amorphous molecular dispersions I: Determination of the degree and mechanism of solid solubility. Pharm Res 21:1598-1606.
21. Vasanthavada M, Tong W, Joshi Y, Kislalioglu MS. 2004. Phase behavior of amorphous molecular dispersions II: Role of hydrogen bonding in solid solubility and phase separation kinetics. Pharm Res 22:440-448.
22. Sun Y, Tao J, Zhang GGZ, Yu L. 2010. Solubilities of crystalline drugs in polymers: An improved analytical method and comparison of solubilities of indomethacin and nifedipine in PVP, PVP/VA, and PVAc. J Pharm Sci 99:4023-4031.
23. Qi S, Belton P, Nollenberger K, Clayden N, Reading M, Craig DQM. 2010. Characterisation and prediction of phase separation in hot-melt extruded solid dispersions: A thermal, microscopic and NMR relaxometry study. Pharm Res 27:1869-1883.
24. Atkins PW. 1998. Physical chemistry. 6th ed. New York City, New York: Freeman, Chapter 20.
25. Perepechko II, 1981. An introduction to polymer physics, A (Beknazarov, Translator). Moscow, Russia: Mir Publishers, Chapter 4.
26. Hancock BC, Shamblin SL, Zografi G. 1995. Molecular mobility of amorphous pharmaceutical solids below their glass transition temperatures. Pharm Res 12:799-806.
27. Klotz IM, Rosenberg RM. 1974. Chemical thermodynamics-Basic theory and methods. 3rd ed. Menlo Park, California: Benjamin-Cummings, Chapters 13 and 14.
28. Klotz IM, Rosenberg RM. 1974. Chemical thermodynamics-Basic theory and methods. 3rd ed. Menlo Park, California: Benjamin-Cummings, Chapter 2.
29. Zhao Y, Inbar P, Chokshi HP, Malick AW, Choi DS. 2011. Prediction of the thermal phase diagram of amorphous solid dispersions by Flory-Huggins theory. J Pharm Sci 100:3196-3207.
30. Vippagunta SR, Wang Z, Hornung S, Krill SL. 2007. Factors affecting the formation of eutectic solid dispersions and their dissolution behavior. J Pharm Sci 96:294-304.
31. Gupta J, Nunes C, Vyas S, Jonnalagadda S. 2011. Prediction of solubility parameters and miscibility of pharmaceutical compounds by molecular dynamics simulations. J Phys Chem B 115:2014-2023.
32. Kumar V, Wang L, Riebe M, Tung HH, Prud'homme RK. 2009. Formulation and stability of itraconazole and odanacatib nanoparticles: Governing physical parameters. Mol Pharm 6:1118-1124.